INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ACCELERATION OF HUMAN HEPATOCYTE ENGRAFTMENT IN HUMANIZED LIVER ANIMALS BY SUPPLEMENTING PARACRINE LIGANDS OR AGONISTS THAT ACTIVATE HUMAN LIVER REGENERATION SIGNALS"

GENEVA, Dec. 10 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/030957) for "ACCELERATION OF HUMAN HEPATOCYTE ENGRAFTMENT IN HUMANIZED LIVER ANIMALS BY SUPPLEMENTING PARACRINE LIGANDS OR AGONISTS THAT ACTIVATE HUMAN LIVER REGENERATION SIGNALS" on May 27, 2025. With publication no. WO/2025/250495, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Joseph Zhe (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10...